The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Antimicrobial Catheter Securement Dressings for the Prevention of Cvc-related Bloodstream Infections in Cancer Patients
Official Title: Chlorhexidine Containing Iv-securement Dressings for the Prevention of Central Venous Catheter-related Blood Stream Infections in Neutropenic Patients: a Randomized Trial
Study ID: NCT01544686
Brief Summary: In neutropenic cancer patients, catheter-related bloodstream infections may cause severe infections and even death. To assess the prophylactic effect of a chlorhexidine coated catheter securement dressing on the incidence of catheter-related bloodstream infections, this open, randomized trial is being carried out. CHG iv Tegaderm securement dressing will be randomized in a 1:1 fashion against Tegaderm Advanced iv securement dressing.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Klinikum Schwabing, Munich, Bavaria, Germany
Klinikum Neuperlach, Munich, Bavaria, Germany
Universitätsklinikum Aachen, Aachen, NRW, Germany
University Hospital Cologne, Cologne, NRW, Germany
Universitätsmedizin Berlin - Charité, Berlin, , Germany
Name: Maria JG Vehreschild, Dr. med.
Affiliation: University Hospital of Cologne
Role: PRINCIPAL_INVESTIGATOR